Citius Oncology, Valuation
| CTOR Stock | 0.85 0.13 13.27% |
Today, the firm appears to be overvalued. Citius Oncology, shows a prevailing Real Value of USD0.82 per share. The current price of the firm is USD0.85. Our model approximates the value of Citius Oncology, from analyzing the firm fundamentals such as current valuation of 116.23 M, and Market Capitalization of 116.23 M as well as examining its technical indicators and probability of bankruptcy.
Price Book 4.5515 | Enterprise Value 116.2 M |
Overvalued
Today
Please note that Citius Oncology,'s price fluctuation is abnormally volatile at this time. Calculation of the real value of Citius Oncology, is based on 3 months time horizon. Increasing Citius Oncology,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Citius stock is determined by what a typical buyer is willing to pay for full or partial control of Citius Oncology,. Since Citius Oncology, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Citius Stock. However, Citius Oncology,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.85 | Real 0.82 | Hype 0.92 | Naive 0.68 |
The intrinsic value of Citius Oncology,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Citius Oncology,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Citius Oncology, helps investors to forecast how Citius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Citius Oncology, more accurately as focusing exclusively on Citius Oncology,'s fundamentals will not take into account other important factors: Citius Oncology, Total Value Analysis
Citius Oncology, is currently estimated to have valuation of 116.23 M with market capitalization of 116.23 M, debt of , and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Citius Oncology, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
116.23 M | 116.23 M |
Citius Oncology, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Citius connotes not a very effective usage of assets in November.About Citius Oncology, Valuation
The stock valuation mechanism determines Citius Oncology,'s current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Citius Oncology, based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Citius Oncology,. We calculate exposure to Citius Oncology,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Citius Oncology,'s related companies.Citius Oncology, Growth Indicators
Investing in growth stocks can be very risky. If the company such as Citius Oncology, does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Shares Short Prior Month | 10.6 K |
Additional Tools for Citius Stock Analysis
When running Citius Oncology,'s price analysis, check to measure Citius Oncology,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Oncology, is operating at the current time. Most of Citius Oncology,'s value examination focuses on studying past and present price action to predict the probability of Citius Oncology,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Oncology,'s price. Additionally, you may evaluate how the addition of Citius Oncology, to your portfolios can decrease your overall portfolio volatility.